Orphan Technologies Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Orphan Technologies General Information

Description

Operator of a clinical-stage biopharmaceutical company, intended to help patients control their homocysteine levels. The company develops novel therapies to reduce homocysteine levels via a targeted mechanism of action, thereby improving the lives of patients suffering from homocystinuria.

Contact Information

Website
www.orphantechnologies.com
Formerly Known As
Orphan Europe (Uk) Limited
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Great Ormond Street Hospital, NHS Foundation
  • London WC1N 3JH
  • England, United Kingdom
Primary Industry
Drug Discovery
Acquirer
Travere Therapeutics
Corporate Office
  • Great Ormond Street Hospital, NHS Foundation
  • London WC1N 3JH
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orphan Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Orphan Technologies‘s full profile, request access.

Request a free trial

Orphan Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage biopharmaceutical company, intended to help patients control their homocysteine levels. The
Drug Discovery
London, United Kingdom
9 As of 2025

Ann Arbor, MI
 

Lexington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Orphan Technologies Competitors (84)

One of Orphan Technologies’s 84 competitors is ONL Therapeutics, a Venture Capital-Backed company based in Ann Arbor, MI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ONL Therapeutics Venture Capital-Backed Ann Arbor, MI
Voyager Therapeutics Formerly VC-backed Lexington, MA
Lexeo Therapeutics Formerly VC-backed New York, NY
Enterome Venture Capital-Backed Paris, France
Ralexar Therapeutics Venture Capital-Backed Wayne, PA
You’re viewing 5 of 84 competitors. Get the full list »

Orphan Technologies Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Orphan Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020264333-A1 Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria Inactive 26-Jun-2019
JP-2020516322-A Optimization of enzyme replacement therapy for the treatment of homocystinuria Active 17-Apr-2017
EP-3612214-A1 Optimization of enzyme replacement therapy for treatment of homocystinuria Pending 17-Apr-2017
EP-3612214-A4 Optimization of enzyme replacement therapy for treatment of homocystinuria Pending 17-Apr-2017 C12Y402/01022

Orphan Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orphan Technologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Orphan Technologies‘s full profile, request access.

Request a free trial

Orphan Technologies FAQs

  • When was Orphan Technologies founded?

    Orphan Technologies was founded in 1996.

  • Where is Orphan Technologies headquartered?

    Orphan Technologies is headquartered in London, United Kingdom.

  • What is the size of Orphan Technologies?

    Orphan Technologies has 9 total employees.

  • What industry is Orphan Technologies in?

    Orphan Technologies’s primary industry is Drug Discovery.

  • Is Orphan Technologies a private or public company?

    Orphan Technologies is a Private company.

  • What is the current valuation of Orphan Technologies?

    The current valuation of Orphan Technologies is .

  • What is Orphan Technologies’s current revenue?

    The current revenue for Orphan Technologies is .

  • Who are Orphan Technologies’s investors?

    NeoPharm has invested in Orphan Technologies.

  • Who are Orphan Technologies’s competitors?

    ONL Therapeutics, Voyager Therapeutics, Lexeo Therapeutics, Enterome, and Ralexar Therapeutics are some of the 84 competitors of Orphan Technologies.

  • When was Orphan Technologies acquired?

    Orphan Technologies was acquired on 12-Nov-2020.

  • Who acquired Orphan Technologies?

    Orphan Technologies was acquired by Travere Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process